G. Cole
Director/Board Member chez CASTLE BIOSCIENCES, INC.
Fortune : 201 758 $ au 31/03/2024
Profil
G.
Bradley Cole is currently an Independent Director at Castle Biosciences, Inc. and Kiniksa Pharmaceuticals Ltd.
He is also the Chief Financial Officer & Director at Genomic Life, Inc. and a Trustee at Biola University, Inc. (California).
Previously, Mr. Cole held the position of Vice President-Finance & Business Development at Guidant Corp.
from 1997 to 2004.
He was also the Chief Financial Officer & Vice President-Finance at EndoVascular Technologies, Inc. from 1994 to 1997.
In addition, he served as the General Manager-Precision Oncology at EXACT Sciences Corp.
from 2019 to 2020 and as the Chief Operating Officer at Genomic Health, Inc. from 2013 to 2014.
Prior to that, he was the Chief Financial Officer & Vice President-Finance at Applied Biosystems, Inc. from 1988 to 1994.
Mr. Cole completed his undergraduate degree at Biola University, Inc. (California) and holds an MBA from San Jose State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
CASTLE BIOSCIENCES, INC.
0,02% | 02/06/2023 | 4 655 ( 0,02% ) | 103 108 $ | 31/03/2024 |
| 29/06/2023 | 5 000 ( 0,01% ) | 98 650 $ | 31/03/2024 |
Postes actifs de G. Cole
| Sociétés | Poste | Début |
|---|---|---|
| CASTLE BIOSCIENCES, INC. | Director/Board Member | 06/12/2018 |
| KINIKSA PHARMACEUTICALS, LTD. | Director/Board Member | 27/07/2020 |
Genomic Life, Inc.
 Genomic Life, Inc. Medical/Nursing ServicesHealth Services Wamberg Genomic Advisors, Inc. engages in the provision of genomic-based programs and services. It offers a comprehensive cancer support program that provide an individual and their family with the dedicated resources, technology, and genetic testing needed to navigate cancer while improving chances of survival. The company was founded in 2017 and is headquartered in San Diego, CA. | Director of Finance/CFO | - |
| Biola University, Inc. (California) | Director/Board Member | - |
Anciens postes connus de G. Cole
| Sociétés | Poste | Fin |
|---|---|---|
| EXACT SCIENCES CORPORATION | Corporate Officer/Principal | 01/04/2020 |
Guidant Corp.
 Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Director of Finance/CFO | 01/05/2004 |
EndoVascular Technologies, Inc.
 EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a private company that makes invasive endovascular systems. The company is based in Menlo Park, CA. The company was founded by Wesley D. Sterman. EndoVascular Technologies was acquired by Guidant Corp. on December 22, 1997 for $145.32 million. | Director of Finance/CFO | 01/12/1997 |
Applied Biosystems, Inc.
 Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Director of Finance/CFO | 01/02/1994 |
| GENOMIC HEALTH, INC. | Director of Finance/CFO | 08/11/2019 |
Formation de G. Cole
| Biola University, Inc. (California) | Undergraduate Degree |
| San Jose State University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| EXACT SCIENCES CORPORATION | Health Technology |
| CASTLE BIOSCIENCES, INC. | Health Technology |
| KINIKSA PHARMACEUTICALS, LTD. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Guidant Corp.
Guidant Corp. Medical SpecialtiesHealth Technology Guidant Corp. manufactures cardiovascular therapeutic devices. The company also provides cardiac and peripheral vascular repair surgical systems. It operates in Europe and Japan. Guidant was founded in 1994 and is headquartered in St. Paul, MN. | Health Technology |
EndoVascular Technologies, Inc.
EndoVascular Technologies, Inc. Medical SpecialtiesHealth Technology Part of Boston Scientific Corp., EndoVascular Technologies, Inc. is a private company that makes invasive endovascular systems. The company is based in Menlo Park, CA. The company was founded by Wesley D. Sterman. EndoVascular Technologies was acquired by Guidant Corp. on December 22, 1997 for $145.32 million. | Health Technology |
Genomic Health, Inc.
 Genomic Health, Inc. Medical SpecialtiesHealth Technology Genomic Health, Inc. engages in the provision of genomic-based diagnostic tests. Its tests analyze the underlying biology of cancers, allowing physicians and patients to make individualized treatment decisions. The firm uses a platform which translates a massive amount of clinical and genomic data into clinically actionable results for treatment planning. The company was founded by Patrick F. Terry, Joffre B. Baker, Randal W. Scott, and Steven Shak in August 2000 and is headquartered in Redwood City, CA. | Health Technology |
Applied Biosystems, Inc.
Applied Biosystems, Inc. Medical SpecialtiesHealth Technology Applied Biosystems, Inc. is a company that provides integrated systems for sequencing, flow cytometry, and various types of PCR. The company is based in Foster City, CA. The company's products cover the entire process from sample preparation to data analysis. The company was founded by Chris Yoo, Marvin H. Caruthers, Michael W. Hunkapiller, and Leroy E. Hood. Applied Biosystems was acquired by Invitrogen Corp. from Applera Corp. on November 21, 2008 for $6,417.85 million. | Health Technology |
Genomic Life, Inc.
Genomic Life, Inc. Medical/Nursing ServicesHealth Services Wamberg Genomic Advisors, Inc. engages in the provision of genomic-based programs and services. It offers a comprehensive cancer support program that provide an individual and their family with the dedicated resources, technology, and genetic testing needed to navigate cancer while improving chances of survival. The company was founded in 2017 and is headquartered in San Diego, CA. | Health Services |
